Clinical Trials Directory

Trials / Conditions / Diffuse Midline Glioma

Diffuse Midline Glioma

9 registered clinical trials studyying Diffuse Midline Glioma — 5 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingGallium Maltolate for the Treatment of Pediatric Patients With Relapsed or Refractory Pediatric High-Grade Gli
NCT07331064
Sarah RumlerPhase 1
Not Yet RecruitingPEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline
NCT06639607
Washington University School of MedicinePhase 1 / Phase 2
RecruitingGD2-CAR T Cells for Pediatric Brain Tumours
NCT05298995
Bambino Gesù Hospital and Research InstitutePhase 1
Active Not RecruitingStudy of B7-H3, EGFR806, HER2, And IL13-Zetakine (Quad) CAR T Cell Locoregional Immunotherapy For Pediatric Di
NCT05768880
Seattle Children's HospitalPhase 1
SuspendedA Phase 2 Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2.0 in Patients with DIPG
NCT05123534
SonALAsense, Inc.Phase 2
CompletedCED of MTX110 Newly Diagnosed Diffuse Midline Gliomas
NCT04264143
Luca SzalontayPhase 1
RecruitingStudy of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Mid
NCT04185038
Seattle Children's HospitalPhase 1
TerminatedOral ONC201 in Adult Recurrent Glioblastoma
NCT02525692
Jazz PharmaceuticalsPhase 2
RecruitingInternational Diffuse Intrinsic Pontine Glioma (DIPG)/Diffuse Midline Glioma (DMG) Registry and Repository
NCT03101813
Children's Hospital Medical Center, Cincinnati—